Articles of Sovereign

News »

Soberana 02, the first Latin American vaccine in phase III trials

Soberana

The Center for State Control of Medicines, Equipment and Medical Devices (Cecmed) has authorized the initiation of phase III clinical trials of the Soberana 02 candidate vaccine, after a rigorous analysis of the documentation submitted by the Finlay Vaccine Institute on findings gathered thus far. President of the Republic of Cuba Miguel Díaz-Canel Bermúdez yesterday also posted a tweet noting that phase III clinical trials were at hand for Soberana 02 and Abdala, in Havana, Santiago de Cuba and Guantánamo, with more than 85,000 volunteers.

News »

Vaccines and Sovereignty (III) The Antigen of Cuban Vaccines Against Covid-19

vacuna-candidatos

The development of a vaccine today requires the existence of today’s conditions for this kind of research. It must begin by looking at the scientific literature for antecedents and ways of doing things that can lead to the implementation of more and more exquisite laboratory procedures and rigorous tests. In our case and for the above reasons, a firm base for the research was already established when the COVID 19 emergency arose.

News »

Vaccines and Sovereignty II: What are Vaccines?

cuba vacunas

The molecules of an invading biological entity that are identified and are accessible to the human immune system are often referred to as “antigens”. They are usually expressed in the outermost parts of the nanoscopic carrier and are a necessary part of its composition. They are the same when found in a virus, in a fungus, in a bacterium, or in the cells of an organ from another being transplanted into our body.

News »

Vaccines and Sovereignty (I): The virus and the immune system

Vacuna Soberana

The word we all speak today with hope is “vaccine.” We have had an absolutely extraordinary 2020’s year. An unexpected and unprecedented pandemic has changed everything, in almost every way for the worse, although there also have been some good consequences. The political defeat of some enemies of our country who did not even know how to lead their powerful country in these extraordinary conditions may have been influenced by this factor, and that is a good consequence.

News »

Soberana in the first phase of clinical trials

Soberana vacuna

The first stage of clinical trials for the definitive validation of Soberana, the Cuban candidate vaccine authorized to begin this phase, began August 24, with the administration of the product to 20 volunteers, between the age of 19 and 59. Over the course of the week, the safety of the candidate vaccine was evaluated and the findings submitted to the Center for State Control of Medications (Cecmed)

News »

How did Cuba’s COVID-19 candidate vaccine come to be named Soberana?

Vacuna Soberana

A name identifies, makes unique, and enamors… It is a calling card and can convey confidence and pride, which is exactly what occurred this month of August, when the people of Cuba heard the long-awaited news that our scientists had come up with an idea, an idea they turned into a vial of vaccine in just three months’ time, as one researcher said.